NL-OMON50135尚未招募不适用
Cardiomyopathy and heart failure risk after treatment for Hodgkin lymphoma or aggressive B cell non-Hodgkin lymphoma - CRYSTAL case-control
ederlands Kanker Instituut0 个研究点目标入组 800 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All lymphoma survivors who meet the inclusion criteria of the P11CHT study or
- •the CRYSTAL cohort study are eligible for the CRYSTAL case-control study. The
- •most important inclusion criteria for the P11CHT and CRYSTAL cohort study are:
- •* Diagnosis of Hodgkin's lymphoma (P11CHT) or aggressive B-cell non-Hodgkin's
- •lymphoma (CRYSTAL cohort)
- •* Treatment for the lymphoma between 1965 and 2005 (P11CHT) or between 1989 and
- •2012 (CRYSTAL cohort)
- •* Age at diagnosis <51 years (P11CHT) or <61 years (CRYSTAL cohort)
- •* Still alive at least 5 years after primary lymphoma treatment
排除标准
- •* A history of (symptomatic) myocardial infarction, valvular heart disease,
- •cardiomyopathy or heart failure before lymphoma diagnosis
- •* Chemotherapy or immunotherapy for a primary malignancy before lymphoma
- •* Radiotherapy to the trunk before lymphoma diagnosis
- •* Myocardial infarction or *CTCAE grade 2 valvular heart disease prior to
- •diagnosis of cardiomyopathy or heart failure
- •* Insufficient understanding of the Dutch language (for survivors receiving the
- •questionnaire)
研究者
相似试验
尚未招募
不适用
Investigation of the effects of heart failure with preserved ejection fraction (HFpEF) on cerebral small vessel diseaseHeart failure with preserved ejection fraction (HFpEF)DRKS00031583niversitätsklinikum Magdeburg102
招募中
不适用
Heart Failure and Related Risk Factors after PreeclampsiaHeart failure and Preeclampsia100192801001027310057166NL-OMON54718Medisch Universitair Ziekenhuis Maastricht2,580
招募中
不适用
Impact of cardiac and autonomic nervous system alterations in cirrhosis patients.CTRI/2021/12/038676Post Graduate Institute of Medical Education and Research
招募中
不适用
Hypertrophic cardiomyopathy: Clinical impact of a prolonged mHealth-based arrhythmia monitoring by single-channel ECGI42.1Obstructive hypertrophic cardiomyopathyDRKS00032144niversitätsklinik für Kardiologie und Internistische Intensivmedizin34
已完成
不适用
Cardiac dysfunction and undiagnosed heart failure in women as a long term effect of the treatment of breast cancer in an unselected primary care settingcardiac dysfunction1008220610018865heart failureNL-OMON39592niversitair Medisch Centrum Groningen700